blog

Reading Testosterone Tests: Timing, Methods and Borderline Results

Understand how timing, food, sleep, illness and laboratory methods shape testosterone results, and why borderline readings may need confirmation.

Reading Testosterone Tests: Timing, Methods and Borderline Results
Share
PinterestFacebookLinkedInRedditTelegramX (Twitter)
Nov 9, 2026
TRT & Emerging Research

A total testosterone test measures the amount of testosterone in a blood sample, including hormone carried by binding proteins and the free fraction. Free testosterone refers to testosterone that is not bound to those proteins. Understanding a result means considering both what was measured and the conditions under which the sample was collected.

Medical Context

This article is for informational purposes and is not medical advice. A qualified clinician should interpret testosterone results alongside symptoms and the wider clinical picture. Decisions about further testing or testosterone therapy require an individual medical assessment rather than a decision based on an article or an isolated laboratory number.

Ranges Need Context

Threshold versus range

A laboratory reference interval provides a comparison range for a measurement. A clinical decision threshold serves a different purpose: it helps guide assessment within a particular guideline. Neither should be treated as a diagnosis by itself.

The European Association of Urology (EAU) recommends repeat total testosterone measurement on at least two separate occasions when the level is below 12 nmol/L, before testosterone therapy. Its diagnostic approach also requires compatible symptoms or signs and reliable morning measurements under fasting conditions.

That threshold is not a universal boundary separating every healthy man from every man with testosterone deficiency. It must remain connected to the assay and clinical setting. It also should not be presented as a complete reference interval with an assumed upper limit.

Biologically, total testosterone describes the overall amount measured in the sample. It does not separately report the free fraction. This distinction matters when binding proteins affect the relationship between total and free testosterone.

A useful starting point is therefore the reference information accompanying the actual laboratory result. The clinician can consider that information alongside the measurement method rather than applying a range taken from an unrelated report.

The assay matters

An assay is the laboratory method used to measure a substance. According to the EAU, LC-MS/MS is the most accurate method for sex-steroid evaluation. The guideline also says that standardized automated immunoassays for total testosterone correlate well with LC-MS/MS.

The practical conclusion is not that every immunoassay result should be rejected. It is that the method belongs in the interpretation, especially when a result is borderline or measurements from different laboratories appear inconsistent.

When reviewing two reports, the clinical question is broader than whether the numbers differ. The laboratory method and sampling conditions also deserve attention. This provides a sounder basis for comparing results without overreading the difference.

Binding changes interpretation

SHBG is a testosterone-binding protein. The EAU strongly recommends measuring SHBG and calculating free testosterone when conditions associated with altered SHBG are present. This adds context when total testosterone does not settle the clinical question.

Calculated free testosterone uses total testosterone, SHBG and albumin. It is therefore a different assessment from simply reading the total testosterone value against its reference interval.

For a borderline result, the relevant question is whether binding proteins could affect interpretation. That is a reason to discuss the relationship between total testosterone and SHBG rather than assuming that total testosterone always provides the complete picture.

Free-testosterone methods differ

The EAU advises against direct free-testosterone immunoassays because they do not accurately estimate free testosterone. It identifies equilibrium dialysis as the most accurate measurement method and calculation using total testosterone, SHBG and albumin as an alternative.

A report labelled “free testosterone” therefore needs a method attached to it. Asking whether the value was measured or calculated helps establish what the result represents. The total-testosterone decision threshold should not be transferred to this different measurement.

Symptoms Need Context

In adult men assessed for late-onset hypogonadism, the EAU requires compatible symptoms or signs together with confirmed low morning testosterone. A result outside the laboratory interval is only one part of that assessment. A laboratory fluctuation and a symptomatic clinical condition are not interchangeable findings.

This distinction is especially important when sampling conditions may have affected the result. A low reading after food intake or during acute illness does not establish persistent symptomatic testosterone deficiency. The clinical assessment must still connect the symptom picture with appropriately confirmed measurements.

The useful discussion begins with the concern that prompted testing and when it began. The clinician can assess whether the reported symptoms or examination findings fit the suspected condition. That assessment should not be replaced by matching a number to an online label.

Testostra's explanation of how symptoms and laboratory findings fit together provides further context for this distinction. The aim is to understand why symptoms matter without assuming that a single result explains them.

What Shapes Results

The EAU identifies several relevant influences on testosterone sampling and interpretation:

  • Daily timing: testosterone is generally higher in the morning.
  • Sleep patterns: sampling time may need different consideration for night-shift workers.
  • Food intake: non-fasting sampling can underestimate total testosterone.
  • Acute illness: a measurement during illness may not reflect the person's usual level.

These factors concern the conditions surrounding a measurement. They should be considered separately from the laboratory method used to analyse the sample.

Morning timing

The EAU recommends total testosterone testing between 07:00 and 10:00 under fasting conditions. Its guidance treats 10:00 as the latest acceptable sampling time for the general male population because levels are generally higher in the morning.

A later sample therefore needs timing context before it is compared with a morning result. The relevant information is the actual collection time, not just the date printed on the report.

This is also why an abnormal initial result may lead to another appointment. Confirmation under suitable conditions helps the clinician assess whether the low finding persists. Repeating a measurement is a confirmation step rather than proof that the original laboratory result was wrong.

Sleep patterns

For night-shift workers, the EAU notes that testosterone's daily rhythm is driven primarily by sleep patterns. It advises sampling after adequate sleep and under fasting conditions. A standard morning clock window should therefore not be applied without considering the person's sleep schedule.

Sleep restriction also has experimental support as an influence on measured testosterone. A report describing a small laboratory experiment involved 10 healthy young men. After a week of sleep opportunity restricted to about five hours nightly, daytime testosterone was lower than during a well-rested condition.

That finding does not establish that one poor night causes hypogonadism. Nor does this small young-male experiment provide a diagnostic rule for men in their thirties through sixties. Its practical relevance is that sleep history belongs in the conversation about sampling conditions.

Food intake

The EAU reports that total and calculated free testosterone fell within 30 minutes of oral glucose administration in the studies it cites. It also reports that non-fasting sampling may underestimate total testosterone by more than 30%.

This is a summary of the cited evidence, not a prediction that every meal causes the same change in every man. The clinical implication is the importance of knowing whether a sample was collected fasting.

When an initial result is borderline, that detail may help explain why a clinician requests confirmation under fasting conditions. It should not become a reason to calculate a corrected testosterone value at home. The guideline supports suitable repeat measurement rather than adding an assumed amount to the original result.

Acute illness

The EAU associates acute disease with functional hypogonadism and advises avoiding testosterone measurement during acute illness. It also notes that testosterone's role in acute illness remains incompletely clarified.

An illness-associated result should therefore be discussed in relation to the person's condition at the time of collection. It should not automatically be treated as evidence of a lasting hormone problem.

For someone who was ill or recovering when tested, a useful question is whether the result reflects a suitable baseline for assessment. The timing of any reassessment is a matter for the clinician rather than a fixed waiting period inferred from this guidance.

Comparing sampling conditions

A meaningful comparison considers the circumstances of both blood draws. Useful details include collection time and fasting status. Sleep schedule and illness at the time are also relevant.

These details help explain why a clinician might repeat total testosterone before moving to further interpretation. They also keep the discussion focused: first establish whether the low measurement is confirmed, then consider whether binding proteins or free-testosterone assessment would clarify the remaining question.

Questions For Care

Ask your physician: “Were my samples collected under suitable conditions; does an abnormal result need confirmation; how do the assay and laboratory reference interval affect interpretation; and would SHBG measurement with an appropriate free-testosterone assessment clarify a borderline result?”

How Testostra helps

Testosterone reports require medical interpretation from a qualified clinician; Testostra supports the educational side by explaining the hormone measurements behind that discussion. Its evidence-led coverage connects total testosterone with free testosterone and SHBG, helping men understand confusing biomarkers while keeping general education separate from personal diagnosis or treatment decisions.

Read Resources

Sources

  1. Improving Sleep Means...
  2. Male Hypogonadism - EAU Guidelines on Sexual and Reproductive …
  3. MALE HYPOGONADISM

Continue reading

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care
November 17, 2026
TRT & Emerging Research

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care

Read Article
Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health
November 17, 2026
Low Testosterone

Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health

Read Article
Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength
November 17, 2026
Lifestyle & Natural Support

Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength

Read Article
Man walking outdoors after exercise in a green urban setting.
GET IN TOUCH

Have a testosterone question or research topic in mind?

Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.

Contact Testostra